首页> 外文会议>Cell culture engineering conference >OVERCOMING SCALE-UP CHALLENGES FOR A FIRST-IN-HUMAN (FIH) ANTIBODY PRODUCTION PROCESS AT THE 2000L SCALE: SUCCESSFUL OPTIMIZATION OF BIOREACTOR EQUIPMENT AND HARVEST CONDITIONS TO IMPROVE PROCESS PERFORMANCE AND PRODUCT YIELD
【24h】

OVERCOMING SCALE-UP CHALLENGES FOR A FIRST-IN-HUMAN (FIH) ANTIBODY PRODUCTION PROCESS AT THE 2000L SCALE: SUCCESSFUL OPTIMIZATION OF BIOREACTOR EQUIPMENT AND HARVEST CONDITIONS TO IMPROVE PROCESS PERFORMANCE AND PRODUCT YIELD

机译:克服2000L规模的第一人(FIH)抗体生产过程的扩大挑战:成功优化生物反应器设备和收获条件,以提高工艺性能和产品产量

获取原文

摘要

During the development and scale-up of a FIH fed-batch cell culture process, we have encountered two major challenges that impacted culture performance and harvest process yield significantly. The first challenge relates to the oxygen requirement for this particular process, where a higher oxygen demand was observed compared to our platform processes. The high oxygen demand is met by increasing agitation and sparging of air and oxygen in bioreactors, but also negatively impacted cell health due to higher gas entrance velocities (GEV) from the higher sparging rate. The observation is exemplified in the manufacturing scale which significantly impacted cell culture performance and antibody production. Further exacerbating this issue, many sparger holes were later found to be plugged leading to a theoretical GEV as high as 300 m/s. Extensive troubleshooting studies were carried out at small scale to confirm the impact of high GEV on this antibody production process and led to the re-design of the sparger for the manufacturing scale. Once implemented, the new sparger successfully mitigated the issue. The second challenge was relating to harvest operation, where the final membrane filter was clogged at the manufacturing scale. Studies were performed at the pilot scale to evaluate different solutions including increasing depth filter area, testing different types of the final filter, and changing the chase buffer at the manufacturing scale. In the end, successful implementation of the new sparger design and optimized harvest conditions led to comparable process performance between the manufacturing scale and the pilot scale. The final process resulted not only in an increase in the overall product yield, but also prevented the need of filter change-outs during the harvest operation, therefore, significantly improving manufacturing ease.
机译:在发育和扩大的氟化批批量细胞培养过程中,我们遇到了两个主要挑战,从而显着影响文化性能和收获过程产量。第一个挑战涉及这种特定过程的氧要求,其中与我们的平台过程相比观察到较高的氧需求。通过增加生物反应器中的空气和氧气的搅拌和喷射来满足高氧需求,而且由于较高的喷射率,由于较高的气体入口速度(GEV),对细胞健康产生负面影响。在制造规模中举例说明了观察,这显着影响细胞培养性能和抗体产生。进一步加剧了这个问题,稍后发现许多喷射孔被堵塞,导致理论GEV高达300米/秒。广泛的故障排除研究是以小规模进行的,以确认高GEV对该抗体生产过程的影响,并导致了用于制造规模的喷射器的重新设计。一旦实施,新的Sparger成功减轻了这个问题。第二次挑战与收获操作有关,其中最终膜过滤器堵塞了制造规模。在试验秤上进行研究,以评估不同的解决方案,包括增加深度过滤区,测试不同类型的最终过滤器,并以制造规模改变追逐缓冲器。最终,成功实施新的Sparger设计和优化的收获条件导致了制造规模和飞行员秤之间的可比过程性能。最终过程不仅导致了总体产品产量的增加,而且还可以防止在收获操作期间需要过滤器变化,因此显着提高了制造的容易性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号